No Data
No Data
Macquarie decrases its stake in Delta-Fly Pharma(4598.JP) to 15.7%
On Nov 6, Macquarie submitted the Change Report to Ministry of Finance. The report shows that Macquarie decreased their holdings in $Delta-Fly Pharma(4598.JP)$, with their joint shareholding ratio
Delta-Fly Pharma Inc.: Update for Expanded Phase I Study of DFP-14927
Macquarie decrases its stake in Delta-Fly Pharma(4598.JP) to 17.66%
On Nov 5, Macquarie submitted the Change Report to Ministry of Finance. The report shows that Macquarie decreased their holdings in $Delta-Fly Pharma(4598.JP)$, with their joint shareholding ratio
Volume change rate ranking (10 o'clock) ~ DMG Morisei, Zain, etc. ranked in.
In the volume change rate ranking, you can understand the market participants' interests such as trends in trading volume by comparing the average volume of the last 5 days with the volume on the delivery day. Top volume change rate [As of 10:32 on November 5th] (Comparison with the average volume of the last 5 days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Price Change Rate <4310> D I 716,700 120,831.7 289.13% 0.20
Stocks hitting the upper or lower price limit in the afternoon session.
■Top gainers: Fuji Kokka E&C <1775>, Sapeet <269A>, SBI Saudi Arabia Stock Listed Investment Trust <3779>, Jay Escom Holdings <4598>, Delta-Fly Pharma <6391>, Kaji Tech <7901>, Matsumoto <7971>, Toli <8732>, Money Partners Group ■Top losers: RSC <4664>, Emplus ※Includes temporary upper and lower limits (indicative values).
Stocks that moved the previous day part 2: M&A Soken, Housecom, ROXX, etc.
Stock name <Code> 30-day closing price ⇒ Day-on-day comparison M&A Research <9552> 2408 -333M & A Negative view on revising the number of M&A advisors. Hino Motors <7205> 406.1 -62.5 Negative view on significantly forecasting a large final deficit due to certification related losses. Goodcom Asset <3475> 829 -79 The impact of rights offerings on high yield stocks is increasing. DAIDO Special Steel <5471> 1211 -116.5 Downward revision of full-year financial estimates. Medley <448
No Data
No Data